Ramesh Kannan
About Ramesh Kannan
Data last updated:
Ramesh Kannan has 25 years in corporate governance. Holds Designated Partner and Director roles. Currently with 5 companies, including Sicp Investment Advisors India Llp and Dhiti Omics Technologies Private Limited. Formerly with 10 companies, such as Qtlomics Technologies Private Limited and 4A Strategies Private Limited. Engaged in General Business, Technology and more. The 4 current companies with reported revenue have a combined latest revenue of ₹173 Cr; the largest is Nu Hospitals Private Limited at ₹154 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nu Hospitals Private Limited U85120KA2006PTC038963 | Director | 17 Dec 2025 | 2006 | ₹154 Cr (FY 2025) | Active |
 Somerset Healthcare Investment Advisors Private Limited U85100MH2014PTC413209 | Director | 08 Sep 2014 | 2014 | ₹10.34 Cr (FY 2025) | Active |
 Dhiti Omics Technologies Private Limited U24100KA2014PTC075038 | Director | 24 Jun 2014 | 2014 | ₹7.24 Cr (FY 2025) | Active |
 Natural Biogenex Private Limited U24239KA2020PTC137602 | Director | 17 Jun 2023 | 2020 | ₹1.44 Cr (FY 2025) | Active |
 Sicp Investment Advisors India Llp ACB-7399 | Designated Partner | 27 Jun 2023 | 2023 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Qtlomics Technologies Private Limited U01400KA2013PTC071008 | Director | 16 Sep 2013 | 2013 | ₹35.44 Cr (FY 2024) | Active |
| 4A Strategies Private Limited U17231KA1997PTC023027 | Director | 30 Jan 2001 | 1997 | – | Strike Off |
| Perspicazz Consulting Private Limited U67190KA2007PTC041519 | Director | 18 Jan 2007 | 2007 | – | Strike Off |
 Genotypic Technology Private Limited U72200KA1998PTC049038 | Director | 28 Sep 2013 | 1998 | ₹39.04 Cr (FY 2025) | Active |
 Vikram Hospital Private Limited U85110KA2000PTC027149 | Nominee Director | 22 Aug 2008 | 2000 | ₹47.65 Cr (FY 2016) | Under Liquidation |
 Manipal Hospitals (Bengaluru) Private Limited U85110KA2009PTC049257 | Director | 27 Feb 2009 | 2009 | ₹279 Cr (FY 2025) | Active |
 Apex Hospitals Private Limited U85110RJ1987PTC004214 | Nominee Director | 17 May 2019 | 1987 | ₹271 Cr (FY 2025) | Active |
| Somerset Healthcare Investment Advisors Iii Private Limited U85300MH2022PTC395762 | Director | 21 Dec 2022 | 2022 | – | Active |
| Tidaldata Solutions Private Limited U72200KA2003PTC032521 | Director | 02 May 2012 | 2003 | – | Strike Off |
| Rx Hospitals Private Limited U85100KA2014PTC076453 | Director | 17 Sep 2014 | 2014 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Kannan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Kannan
Ramesh Kannan has 25 years in corporate governance. Holds Designated Partner and Director roles. Currently with 5 companies, including Sicp Investment Advisors India Llp and Dhiti Omics Technologies Private Limited. Formerly with 10 companies, such as Qtlomics Technologies Private Limited and 4A Strategies Private Limited. Engaged in General Business, Technology and more. The 4 current companies with reported revenue have a combined latest revenue of ₹173 Cr; the largest is Nu Hospitals Private Limited at ₹154 Cr (FY 2025).
Ramesh Kannan is associated with 5 companies as Designated Partner and Director, including Nu Hospitals Private Limited (₹154 Cr), Somerset Healthcare Investment Advisors Private Limited (₹10.34 Cr), Dhiti Omics Technologies Private Limited (₹7.24 Cr).
Ramesh Kannan has expertise in General Business, Technology and other sectors.
Ramesh Kannan has 25 years in corporate governance.
By reported revenue, the largest current company of Ramesh Kannan is Nu Hospitals Private Limited, with revenue of ₹154 Cr (FY 2025).
The 4 current companies of Ramesh Kannan that report revenue have a combined latest revenue of ₹173 Cr.
Ramesh Kannan currently holds positions at 5 companies: Nu Hospitals Private Limited (₹154 Cr), Somerset Healthcare Investment Advisors Private Limited (₹10.34 Cr), Dhiti Omics Technologies Private Limited (₹7.24 Cr), Natural Biogenex Private Limited (₹1.44 Cr), Sicp Investment Advisors India Llp.